Rocaltrol and Systemic lupus erythematosus - a phase IV clinical study of FDA data


Systemic lupus erythematosus is found among people who take Rocaltrol, especially for people who are female, 30-39 old.

The phase IV clinical study analyzes which people take Rocaltrol and have Systemic lupus erythematosus. It is created by eHealthMe based on reports of 7,006 people who have side effects when taking Rocaltrol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 28, 2022

7,006 people reported to have side effects when taking Rocaltrol.
Among them, 15 people (0.21%) have Systemic lupus erythematosus.

What is Rocaltrol?

Rocaltrol has active ingredients of calcitriol. It is often used in hypoparathyroidism. eHealthMe is studying from 7,047 Rocaltrol users for its effectiveness, alternative drugs and more.

What is Systemic lupus erythematosus?

Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue) is found to be associated with 2,147 drugs and 1,459 conditions by eHealthMe.

Number of Rocaltrol and Systemic lupus erythematosus reports submitted per year:

Could Rocaltrol cause Systemic lupus erythematosus?

Gender of people who have Systemic lupus erythematosus when taking Rocaltrol *:

  • female: 93.33 %
  • male: 6.67 %

Age of people who have Systemic lupus erythematosus when taking Rocaltrol *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 75.0 %
  • 40-49: 8.33 %
  • 50-59: 8.33 %
  • 60+: 8.33 %

Common drugs people take besides Rocaltrol *:

  1. Famotidine: 5 people, 33.33%
  2. Enalapril Maleate: 4 people, 26.67%
  3. Dipyridamole: 4 people, 26.67%
  4. Nifedipine: 4 people, 26.67%
  5. Prednisolone: 4 people, 26.67%
  6. Folic Acid: 3 people, 20.00%
  7. Bosentan: 3 people, 20.00%
  8. Prednisone: 3 people, 20.00%
  9. Povidone Iodine: 3 people, 20.00%
  10. Chloroquine Phosphate: 2 people, 13.33%

Common side effects people have besides Systemic lupus erythematosus *:

  1. Malaise (a feeling of general discomfort or uneasiness): 4 people, 26.67%
  2. Pericarditis (inflammation of the pericardium): 4 people, 26.67%
  3. Fever: 4 people, 26.67%
  4. Blood Lactate Dehydrogenase Increased: 4 people, 26.67%
  5. Blood Creatine Phosphokinase Increased: 4 people, 26.67%
  6. Disease Progression: 3 people, 20.00%
  7. Nephrogenic Anaemia (anaemia due to kidney disease): 2 people, 13.33%
  8. Nausea And Vomiting: 2 people, 13.33%
  9. Multi-Organ Failure (multisystem organ failure): 2 people, 13.33%
  10. Neuralgia (pain in one or more nerves): 2 people, 13.33%

Common conditions people have *:

  1. Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 20.00%
  2. Autoimmune Disorder (a condition in which the immune system attacks the body's normal substances and tissue): 3 people, 20.00%
  3. Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 2 people, 13.33%
  4. Idiopathic Thrombocytopenic Purpura (Itp) (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 2 people, 13.33%
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 13.33%
  6. Gastrointestinal Candidiasis (fungal infection of gastrointestinal tract): 2 people, 13.33%
  7. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 13.33%
  8. Calcium Deficiency (lack of calcium): 2 people, 13.33%
  9. Hepatitis C: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Rocaltrol and have Systemic lupus erythematosus?

Check whether Systemic lupus erythematosus is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Systemic lupus erythematosus and when was it recovered:

Expand to all the drugs that have ingredients of calcitriol:

Alternative drugs to, pros and cons of Rocaltrol:

Common Rocaltrol side effects:

Browse all side effects of Rocaltrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Systemic lupus erythematosus treatments and more:

COVID vaccines that are related to Systemic lupus erythematosus:

Common drugs associated with Systemic lupus erythematosus:

All the drugs that are associated with Systemic lupus erythematosus:

Common conditions associated with Systemic lupus erythematosus:

All the conditions that are associated with Systemic lupus erythematosus:

How the study uses the data?

The study uses data from the FDA. It is based on calcitriol (the active ingredients of Rocaltrol) and Rocaltrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: